Search results for “site:ncbi.nlm.nih.gov”

Page 10 of about 437 results

ncbi.nlm.nih.gov pubmed › 33017479

Headache in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Narrative Review

According to the Centers for Disease Control, common symptoms of human coronavirus include fever, cough, runny nose, sore throat, and headache. In the case of SARS-CoV-2, there are limited reports about headaches, one of the most common...

ncbi.nlm.nih.gov pubmed › 33035373

Comparison of influenza type A and B with COVID-19: A global systematic review and meta-analysis on clinical, laboratory and radiographic findings

We compared clinical symptoms, laboratory findings, radiographic signs and outcomes of COVID-19 and influenza to identify unique features. Depending on the heterogeneity test, we used either random or fixed-effect models to analyse the...

ncbi.nlm.nih.gov pubmed › 33068263

Immune Therapy, or Antiviral Therapy, or Both for COVID-19: A Systematic Review

Beyond the supportive therapy, up to now the best therapeutic approach for COVID-19 may be a three-step combination therapy, including remdesivir 100 mg/day (200 mg loading dose on first day) in the first stage of the disease, and combined...

ncbi.nlm.nih.gov pubmed › 33126180

COVID-19 diagnosis -A review of current methods

A fast and accurate self-testing tool for COVID-19 diagnosis has become a prerequisite to comprehend the exact number of cases worldwide and to take medical and governmental actions accordingly. SARS-CoV-2 (formerly, 2019-nCoV) infection...

ncbi.nlm.nih.gov pubmed › 33146028

Vitamin D deficiency aggravates COVID-19: systematic review and meta-analysis

There is still limited evidence regarding the influence of vitamin D in people with COVID-19. In this systematic review and meta-analysis, we analyze the association between vitamin D deficiency and COVID-19 severity, via an analysis of...

ncbi.nlm.nih.gov pubmed › 33217763

Severe acute respiratory syndrome coronavirus 2 infection reaches the human nervous system: How?

Without protective and/or therapeutic agents the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection known as coronavirus disease 2019 is quickly spreading worldwide. It has surprising transmissibility potential, since...

ncbi.nlm.nih.gov pubmed › 33294423

A Systematic Review on the Investigation of SARS-CoV-2 in Semen

The novel nature of SARS-CoV-2 has limited the number and size of studies on semen. Nevertheless, the current literature, while limited, has confirmed the presence of SARS-CoV-2 in semen in one out of the eight reported studies and...

ncbi.nlm.nih.gov pubmed › 33339696

Diagnosis of COVID-19 for controlling the pandemic: A review of the state-of-the-art

To date, health organizations and countries around the world are struggling to completely control the spread of the coronavirus disease 2019 (COVID-19). Scientists and researchers are developing tests for the rapid detection of individuals...

ncbi.nlm.nih.gov pubmed › 33415116

The Need for Antiviral Drugs for Pandemic Coronaviruses From a Global Health Perspective

Respiratory failure due to SARS-CoV-2 has caused widespread mortality, creating an urgent need for effective treatments and a long-term need for antivirals for future emergent coronaviruses. Pharmacotherapy for respiratory viruses has...

ncbi.nlm.nih.gov pubmed › 33432259

Comparison of the SARS-CoV-2 (2019-nCoV) M protein with its counterparts of SARS-CoV and MERS-CoV species

<span><i>Coronaviruses</i> M proteins are well-represented in the major protein component of the viral envelope. During the viral assembly, they play an important role by association with all other viral structural proteins. Despite their...